Incorporating gene co-expression network in identification of cancer prognosis markers

[1]  G. Sauter,et al.  Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer. , 2010, Human pathology.

[2]  Hongyu Zhao,et al.  An Evaluation of Gene Module Concepts in the Interpretation of Gene Expression Data , 2010 .

[3]  J. Gray,et al.  The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer , 2010, Breast Cancer Research.

[4]  R. Sutherland,et al.  CDK inhibitors as potential breast cancer therapeutics: new evidence for enhanced efficacy in ER+ disease , 2009, Breast Cancer Research.

[5]  Yusuke Nakamura,et al.  Involvement of RQCD1 overexpression, a novel cancer-testis antigen, in the Akt pathway in breast cancer cells. , 2009, International journal of oncology.

[6]  Ivan Merelli,et al.  Ontological Enrichment of the Genes-to-Systems Breast Cancer Database , 2009, MTSR.

[7]  M. Hung,et al.  14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition. , 2009, Cancer cell.

[8]  Karl J. Dykema,et al.  Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer , 2009, Proceedings of the National Academy of Sciences.

[9]  Ming-Tzu Tsai,et al.  SCUBE2 suppresses breast tumor cell proliferation and confers a favorable prognosis in invasive breast cancer. , 2009, Cancer research.

[10]  Anne-Laure Boulesteix,et al.  Survival prediction using gene expression data: A review and comparison , 2009, Comput. Stat. Data Anal..

[11]  M. Rizzi,et al.  Curcumin as a Possible Lead Compound against Hormone‐Independent, Multidrug‐Resistant Breast Cancer , 2009, Annals of the New York Academy of Sciences.

[12]  James Bailey,et al.  A voting approach to identify a small number of highly predictive genes using multiple classifiers , 2009, BMC Bioinformatics.

[13]  A. G. Gittenberger-de Groot,et al.  The lim domain only protein 7 is important in zebrafish heart development , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[14]  Jian Huang,et al.  Penalized feature selection and classification in bioinformatics , 2008, Briefings Bioinform..

[15]  M. Neuberger,et al.  Early-onset lymphoma and extensive embryonic apoptosis in two domain-specific Fen1 mice mutants. , 2008, Cancer research.

[16]  C. Mecucci,et al.  Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia. , 2008, Blood.

[17]  R. Salunga,et al.  A Five-Gene Molecular Grade Index and HOXB13:IL17BR Are Complementary Prognostic Factors in Early Stage Breast Cancer , 2008, Clinical Cancer Research.

[18]  Y. Furukawa,et al.  CDC20, a potential cancer therapeutic target, is negatively regulated by p53 , 2008, Oncogene.

[19]  Gemma K. Alderton.  Tumour suppressors: One-hit wonder , 2008, Nature Reviews Cancer.

[20]  Bin Zhang,et al.  Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R , 2008, Bioinform..

[21]  A. Möller,et al.  Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer , 2008, The Journal of pathology.

[22]  A. Ørbo,et al.  Gene expression in endometrial cancer cells (Ishikawa) after short time high dose exposure to progesterone , 2008, Steroids.

[23]  A. Olshen,et al.  Pathway activation in large B-cell non-Hodgkin lymphoma cell lines by doxorubicin reveals prognostic markers of in vivo response , 2008, Leukemia & lymphoma.

[24]  C. Robert.  Discussion of "Sure independence screening for ultra-high dimensional feature space" by Fan and Lv. , 2008 .

[25]  L. O’Driscoll,et al.  Drug metabolism-related genes as potential biomarkers: analysis of expression in normal and tumour breast tissue , 2008, Breast Cancer Research and Treatment.

[26]  Y. Jeon,et al.  Suppression of adenine nucleotide translocase-2 by vector-based siRNA in human breast cancer cells induces apoptosis and inhibits tumor growth in vitro and in vivo , 2008, Breast Cancer Research.

[27]  Giosuè Lo Bosco,et al.  Associations between Notch-2, Akt-1 and HER2/neu Expression in Invasive Human Breast Cancer: A Tissue Microarray Immunophenotypic Analysis on 98 Patients , 2007, Pathobiology.

[28]  David E. Booth.  Cancer Diagnostics With DNA Microarrays , 2007, Technometrics.

[29]  Q. Ye,et al.  Identification of MSRA gene on chromosome 8p as a candidate metastasis suppressor for human hepatitis B virus-positive hepatocellular carcinoma , 2007, BMC Cancer.

[30]  Tetsuya Takakuwa,et al.  Promoter Hypermethylation of the Bone Morphogenetic Protein-6 Gene in Malignant Lymphoma , 2007, Clinical Cancer Research.

[31]  Jun Dong,et al.  Understanding network concepts in modules , 2007, BMC Systems Biology.

[32]  M. Jett,et al.  Metastatic progression and gene expression between breast cancer cell lines from African American and Caucasian women , 2007, Journal of carcinogenesis.

[33]  Stefano A Pileri,et al.  Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. , 2007, The Journal of clinical investigation.

[34]  S Beck,et al.  RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer , 2007, Oncogene.

[35]  Jan Delabie,et al.  Transformation of follicular lymphoma to diffuse large B‐cell lymphoma proceeds by distinct oncogenic mechanisms , 2007, British journal of haematology.

[36]  Min Zhang,et al.  Expression of PLK1 and survivin in diffuse large B-cell lymphoma , 2007, Leukemia & lymphoma.

[37]  Andy M. Yip,et al.  Gene network interconnectedness and the generalized topological overlap measure , 2007, BMC Bioinformatics.

[38]  Jianqing Fan,et al.  Sure independence screening for ultrahigh dimensional feature space , 2006, math/0612857.

[39]  Roberto Piva,et al.  Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes. , 2006, The Journal of clinical investigation.

[40]  Steen Knudsen.  Cancer Diagnostics with DNA Microarrays: Knudsen/Cancer Diagnostics with DNA Microarrays , 2006 .

[41]  S. Horvath,et al.  Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target , 2006, Proceedings of the National Academy of Sciences.

[42]  Gema Moreno-Bueno,et al.  Transcriptional profiling of MCF7 breast cancer cells in response to 5‐Fluorouracil: Relationship with cell cycle changes and apoptosis, and identification of novel targets of p53 , 2006, International journal of cancer.

[43]  S. Horvath,et al.  Evidence for anti-Burkitt tumour globulins in Burkitt tumour patients and healthy individuals. , 1967, British Journal of Cancer.

[44]  Alan Mackay,et al.  The effect of the stromal component of breast tumours on prediction of clinical outcome using gene expression microarray analysis , 2006, Breast Cancer Research.

[45]  Guy Leclercq,et al.  p53 and breast cancer, an update. , 2006, Endocrine-related cancer.

[46]  David M. Rocke,et al.  Dimension Reduction for Classification with Gene Expression Microarray Data , 2006, Statistical applications in genetics and molecular biology.

[47]  Y. Leea,et al.  Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target , 2006 .

[48]  S. Horvath,et al.  Gene connectivity, function, and sequence conservation: predictions from modular yeast co-expression networks , 2006, BMC Genomics.

[49]  Jian Huang,et al.  Regularized ROC method for disease classification and biomarker selection with microarray data , 2005, Bioinform..

[50]  Xiuqin Wang,et al.  Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation marker in human solid tumors than its activity. , 2005, Oncology reports.

[51]  Giovanni Parmigiani,et al.  Searching for differentially expressed gene combinations , 2005, Genome Biology.

[52]  S. Horvath,et al.  A General Framework for Weighted Gene Co-Expression Network Analysis , 2005, Statistical applications in genetics and molecular biology.

[53]  H. Moriwaki,et al.  Expression of survivin and of antigen detected by a novel monoclonal antibody, T332, is associated with outcome of diffuse large B‐cell lymphoma and its subtypes , 2005, Pathology international.

[54]  Tak W. Mak,et al.  Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors , 2005, Nature.

[55]  F. Bertucci,et al.  Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to Chemotherapy , 2004, Cancer Research.

[56]  Homin K. Lee,et al.  Coexpression analysis of human genes across many microarray data sets. , 2004, Genome research.

[57]  Limsoon Wong,et al.  The practical Bioinformatician , 2004 .

[58]  Ash A. Alizadeh,et al.  Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. , 2004, The New England journal of medicine.

[59]  Kohsuke Imai,et al.  Clinical course of patients with WASP gene mutations. , 2004, Blood.

[60]  Raghubir P. Sharma,et al.  Sodium selenite-induced apoptosis in murine B-lymphoma cells is associated with inhibition of protein kinase C-delta, nuclear factor kappaB, and inhibitor of apoptosis protein. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[61]  Yong Liu,et al.  Functional identification of distinct sets of antitumor activities mediated by the FKBP gene family , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[62]  Philip M. Long,et al.  Breast cancer classification and prognosis based on gene expression profiles from a population-based study , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[63]  Eric R. Ziegel,et al.  The Elements of Statistical Learning , 2003, Technometrics.

[64]  M. West,et al.  Gene expression predictors of breast cancer outcomes , 2003, The Lancet.

[65]  Ash A. Alizadeh,et al.  Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. , 2003, Blood.

[66]  L. Staudt,et al.  The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. , 2003, Cancer cell.

[67]  Kai Xu,et al.  CACNA2D2-mediated apoptosis in NSCLC cells is associated with alterations of the intracellular calcium signaling and disruption of mitochondria membrane integrity , 2003, Oncogene.

[68]  A. Barabasi,et al.  Hierarchical Organization of Modularity in Metabolic Networks , 2002, Science.

[69]  L. Staudt,et al.  The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.

[70]  Colin Campbell,et al.  Identification of amplified and expressed genes in breast cancer by comparative hybridization onto microarrays of randomly selected cDNA clones , 2002, Genes, chromosomes & cancer.

[71]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[72]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[73]  M. Mathews,et al.  Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR , 2000, Oncogene.

[74]  M. Lewis,et al.  Regulated expression patterns of IRX-2, an Iroquois-class homeobox gene, in the human breast , 1999, Cell and Tissue Research.

[75]  S. Shichijo,et al.  Expression of the SART‐1 tumor rejection antigen in breast cancer , 1999, International journal of cancer.

[76]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[77]  J. Crocker,et al.  Correlation between PCNA and AgNOR scores in non-Hodgkin's lymphomas using sequential staining technique. , 1993, Journal of clinical pathology.

[78]  M. Tzardi,et al.  Proliferating cell nuclear antigen (PCNA) expression in childhood lymphomas. , 1992, Acta morphologica Hungarica.

[79]  Rupert G. Miller,et al.  Survival Analysis , 2022, The SAGE Encyclopedia of Research Design.